Purpose & when to use

Device Challenge Aerosol testing evaluates how sensors, collectors, respiratory-protection products, and mitigation devices respond to controlled biological or particle-tracer aerosols. To establish the reference challenge concentration, ARE Labs combines Collison nebulizers with controlled airflow, environmental logging, and qPCR, ddPCR, or fluorescence quantitation. The work is conducted under ISO 17025 controls, with methods aligned to ASTM, EN, or 42 CFR frameworks when appropriate for the device class:

  1. Bioaerosol detector sensitivity mapping for fixed or fieldable instruments, using Collison-generated targets and ISO 17025 reference sampling to define detection limits.
  2. Respiratory-protection product comparisons under ASTM F2299, EN 149, or 42 CFR Part 84 context, using particle counters and tracer aerosols to map penetration and response.
  3. Medical-mask or barrier-device challenge studies aligned to ASTM F2101 or EN 14683, using biological or fluorescent tracers to compare capture performance.
  4. Air-treatment and collector validation under ISO 17025 controls, using chamber or duct releases with reference impingers, filters, and qPCR or ddPCR quantitation.
  5. Alert-logic and false-alarm evaluation for bioaerosol sensors, using defined backgrounds, blanks, and replicate release sequences within an ISO 17025 quality system.

Use this service when a device must respond to a defined aerosol challenge rather than a nominal specification. Before method selection, the study plan defines the target, background conditions, airflow field, decision threshold, and reference recovery workflow.

Built for detectors, collectors, and protection devices

Device challenge aerosol studies span products that sense, capture, filter, or reduce bioaerosols and particle tracers. The setup adapts to ISO, ASTM, EN, or 42 CFR expectations without treating every device as the same fixture.

  • DetectorsBioaerosol sensors and alarms
  • CollectorsSamplers and capture devices
  • RespiratorsFiltering facepiece programs
  • Medical masksBarrier and BFE studies
  • Air cleanersRoom and duct mitigation

Instrumentation & measurement ranges

Challenge design accounts for the target aerosol, device inlet geometry, environmental sensitivity, and the endpoint used for reference quantitation.

1 - 1000 L/minchallenge-flow

Collison and related nebulizers

Generate controlled biological, surrogate, or particle-tracer aerosols into a chamber, duct, or device inlet with release rate documented for each condition.

20 - 80 RHcondition-control

Environmental and airflow control

Flow, temperature, and relative humidity are logged through each challenge so detector response and recovery can be interpreted against the exposure environment.

0.5 - 30 L/minsampler-flow

Inline reference samplers

Impingers, filter holders, or capture trains collect reference aerosol at defined locations and intervals for recovery, blanks, and concentration calculation.

10 - 100000000 copiesquantitation

qPCR, ddPCR, and fluorescence endpoints

Biological and fluorescent tracer quantitation converts collected challenge material into reference concentration, recovery, and dose-response inputs.

Test method options

MethodStrengthsTradeoffAligned with
Detector dose-response mapping
  • Defines limit of detection, response curve, and usable alert threshold for bioaerosol detectors under ISO 17025 records.
  • Pairs device output with reference sampler recovery so algorithm tuning is based on measured challenge concentration.
Requires multiple concentrations, blanks, and replicates, so test time grows with each target organism or surrogate.
ISO 17025
Respiratory-protection particle challenge
  • Supports respirator and filtration-media comparisons using ASTM F2299, EN 149, or 42 CFR Part 84 aerosol challenge context.
  • Reports penetration or device response alongside pressure, flow, and environmental records for design or supplier decisions.
Fixture sealing, face velocity, and challenge aerosol selection must be locked before data can be compared across products.
ASTM F2299EN 14942 CFR Part 84
Medical-barrier bioaerosol challenge
  • Aligns medical mask and barrier-device studies to ASTM F2101 or EN 14683 bacterial filtration efficiency context.
  • Uses biological or fluorescent tracers with reference samplers to compare capture performance, breakthrough, or device response.
Method fit depends on product geometry and claim language; non-mask devices often need a documented adaptation rationale.
ASTM F2101EN 14683

Setup configurations

Each device challenge begins with the aerosol target, device placement, and decision threshold. Before the first run, the study plan documents the release location, mixing strategy, reference sampler positions, environmental setpoints, replicate logic, device settings, and data-capture responsibilities. Together, these details define the test configuration used for each challenge run:

Device interfaces

Device-under-test placement in a chamber, duct, fixture, or inlet adapter with geometry photographed and recorded.

Flow & actuation profiles

Defined challenge airflow, device operating mode, and release timing; detector sampling cadence and internal logs captured when available.

Environmental controls

Temperature, RH, and background aerosol conditions logged before, during, and after each challenge sequence.

Sample numbers

Replicate challenges per condition plus blanks, background runs, and device-off controls sized to the decision risk.

Calibration & verification

Sampler flow, nebulizer output checks, assay controls, and environmental sensors verified within the study record.

Methods anchored to the standards that matter

The quality framework follows the device class and the decision the data need to support. ISO 17025 is the accredited laboratory anchor. ASTM, EN, and 42 CFR frameworks are used as aligned methods only when the product and claim support them.

  • ISO 17025AccreditedTesting-laboratory competence, traceable records, calibration control, and uncertainty contributors.
  • ASTM F2101AlignedBacterial filtration efficiency context for medical mask and barrier-device challenges.
  • ASTM F2299AlignedParticle penetration context for respirator media and filtration comparisons.
  • EN 149AlignedEuropean filtering half-mask context for aerosol penetration and classification studies.

Key data outputs & reporting

Device challenge aerosol reports tie the device response to a measured reference challenge, not the generator setting alone. Each report includes concentration estimates, response timing, alert calls, recovery checks, environmental logs, and the supporting QA / QC records. These records and results show which findings can be compared, whether the data are fit for the intended purpose, and how each conclusion was reached under the tested conditions.

Primary outputs

  • Dose-response summary showing device signal, alert state, or capture result versus measured reference concentration.
  • Time-to-detect and alert-rate tables, including true positive, false positive, and false negative counts when the device output supports classification.
  • Reference sampler recovery, background, and blank results with qPCR, ddPCR, fluorescence, or particle-count endpoint details.
  • Environmental and flow logs tied to each challenge sequence, including RH, temperature, airflow, release timing, and device operating mode.

Deliverables

#FormatContents
01PDF reportMethods, controls, challenge conditions, response summaries, and conclusions.
02CSV / XLSX datasetsTime series, reference concentrations, alert calls, sampler recovery, and environmental logs.
03FiguresDose-response plots, time-to-detect distributions, and annotated challenge timelines.

QA / QC & data integrity

Challenge studies use a documented QA / QC framework sized to the aerosol target, device class, and quantitation endpoint. Controls separate device response from background, sampler recovery, assay variability, and environmental drift. ARE Labs maintains the records under its ISO 17025 quality system from sample receipt through data review and final reporting.

Reference sampler blanks, background runs, and device-off controls included with every challenge sequence.

Replicate challenge runs and repeated sequences quantify run-to-run variability and response reliability.

Recovery verification for impingers, filters, extraction steps, and tracer assays where applicable.

Calibration and verification records for sampler flow, airflow, RH, temperature, and quantitation instruments.

Chain of custody for organisms, tracers, devices, collected samples, and extracted materials.

RESEARCH / THIS WORK IN PRACTICE

Real studies. Measured evidence.

Explore published studies connected to device challenge aerosol. Each explains the study question, approach and findings.

View related studies (2)
Air-Cleaner Performance

Glow Guardian Air-Purifying Candle: Concept to Market

The work helped Glow Guardian move from an early concept to a public-facing product story supported by controlled bioaerosol data and a granted patent.

Selected finding
The final broad-range study showed measurable reductions across virus surrogates, bacteria, mold spores, and bacterial endospores.
BioaerosolAir cleanerFormulation development
Air-Cleaner Performance

First-Minute Bioaerosol Testing for Active-in-Air Devices

The method addressed a product-mechanism question that standard chamber decay testing does not isolate: what viable bioaerosol concentration remains one minute after a new challenge enters room air that has already been treated?

Selected finding
The method compared viable bioaerosol concentration after a one-minute post-aerosolization mixing period in matched control and pretreated-room conditions.
BioaerosolAir cleanerDevice evaluation

Study-specific findings do not guarantee performance for another product.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
17025Accredited testing
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

The answers below address common scoping questions from bioaerosol detector teams, air-treatment developers, respiratory-protection programs, and medical-device teams. They cover surrogate selection, concentration range, study controls, time-to-detect outputs, applicable standards, reference quantitation, and deliverable formats. When a device geometry, target aerosol, or regulatory framework falls outside these examples, ARE Labs can develop a study-specific approach for the project.

Q.Can you challenge with non-viable surrogates?
A.Yes. Fluorescent or biological tracers are common choices when viability is not required. ARE Labs selects the surrogate based on the device response mechanism, biosafety requirements, and reference quantitation endpoint.
Q.How do you define the challenge concentration range?
A.We bracket the expected detection threshold, then add challenge points above and below it to define the response curve. Background concentration, sampling volume, and assay sensitivity determine the practical concentration range.
Q.Do you provide ROC and time-to-detect metrics?
A.Yes, when the device output supports classification. ARE Labs can report time-to-detect, alert rate, sensitivity, false positives, and false negatives against measured reference concentrations.
Q.What controls are included?
A.Typical controls include device-off baselines, sampler blanks, background runs, and replicate challenge sequences. Recovery checks are added for impingers, filters, extraction steps, and tracer assays as applicable.
Q.Which standards apply to my device?
A.The product category determines the applicable framework. Respirators may point to EN 149 or 42 CFR Part 84, medical masks to ASTM F2101 or EN 14683, and sensor studies to records maintained under ISO 17025.